Cytosorbents Corporation
CTSO
$1.10
-$0.06-5.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.88M | -2.33M | -4.14M | -6.36M | -6.57M |
| Total Depreciation and Amortization | 425.60K | 428.80K | 446.50K | 443.20K | 789.30K |
| Total Amortization of Deferred Charges | 190.40K | 190.40K | -10.70K | 10.70K | -- |
| Total Other Non-Cash Items | 6.44M | -2.02M | 1.68M | 2.44M | -984.80K |
| Change in Net Operating Assets | -1.52M | 1.28M | -2.77M | -1.37M | 362.40K |
| Cash from Operations | -2.34M | -2.46M | -4.79M | -4.83M | -6.41M |
| Capital Expenditure | -69.20K | -151.70K | -18.20K | -45.20K | -95.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.00K | -146.60K | -101.60K | -81.80K | -40.40K |
| Cash from Investing | -124.20K | -298.40K | -119.90K | -127.00K | -135.90K |
| Total Debt Issued | 0.00 | 0.00 | 15.00M | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -4.38M | -625.00K | -- |
| Issuance of Common Stock | 166.90K | -- | 0.00 | 53.20K | 12.21M |
| Repurchase of Common Stock | -- | -41.50K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -57.60K | -790.40K | -- | -- |
| Cash from Financing | 166.90K | -99.00K | 9.83M | -571.80K | 12.21M |
| Foreign Exchange rate Adjustments | -105.90K | 85.20K | -69.80K | 5.80K | -98.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.41M | -2.77M | 4.85M | -5.52M | 5.57M |